Yahoo · Nov 12, 2026
Rockwell Medical, Inc. Q3 2026 Earnings Call Summary
Moby summary of Rockwell Medical, Inc.'s Q3 2026 earnings call
RM
NASDAQ · RMTI
Rockwell Medical, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$7.03
Down-$0.35 (-4.74%)
Updated Nov 15, 2026, 6:29 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 32.73M
- P/E ratio
- -6.23
- Dividend yield
- 0.00%
- 52-week range
- $0.60 – $8.90
- Volume
- 42.45K
- Avg. volume
- 636.92K
Price performance · RMTI
RMTI price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
RMTI closed at $7.03 after 20 trading sessions, down 6.14% for the selected period.
- Last close
- $7.03
- Period change
- -6.14%
- Period low
- $6.86
- Period high
- $8.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $7.00 | $7.535 | $6.81 | $7.03 | 42.45K |
| Nov 12, 2026 | $7.15 | $7.63 | $6.90 | $7.38 | 15.67K |
| Nov 11, 2026 | $7.30 | $7.5512 | $7.02 | $7.08 | 20.4K |
| Nov 10, 2026 | $7.54 | $7.66 | $7.31 | $7.31 | 17.05K |
| Nov 9, 2026 | $7.63 | $7.76 | $7.37 | $7.52 | 19.89K |
| Nov 6, 2026 | $7.52 | $7.99 | $7.22 | $7.73 | 16.15K |
| Nov 5, 2026 | $8.11 | $8.11 | $7.60 | $7.60 | 32.96K |
| Nov 4, 2026 | $7.96 | $8.39 | $7.83 | $8.05 | 17.31K |
| Nov 3, 2026 | $7.45 | $8.2399 | $7.45 | $8.09 | 63.36K |
| Nov 2, 2026 | $7.20 | $7.222 | $6.75 | $6.91 | 10.66K |
| Oct 30, 2026 | $6.94 | $7.08 | $6.7101 | $7.07 | 39.54K |
| Oct 29, 2026 | $6.975 | $7.31 | $6.975 | $7.31 | 4.35K |
| Oct 28, 2026 | $6.85 | $7.35 | $6.70 | $7.31 | 21.13K |
| Oct 27, 2026 | $7.00 | $7.14 | $6.6801 | $6.86 | 29.88K |
| Oct 26, 2026 | $6.91 | $7.27 | $6.86 | $7.00 | 11.12K |
| Oct 23, 2026 | $7.06 | $7.62 | $6.94 | $6.94 | 13.26K |
| Oct 22, 2026 | $7.03 | $7.06 | $6.87 | $7.06 | 6.67K |
| Oct 21, 2026 | $7.18 | $7.5044 | $7.05 | $7.08 | 23.78K |
| Oct 20, 2026 | $7.41 | $7.48 | $7.23 | $7.23 | 12.18K |
| Oct 19, 2026 | $7.4306 | $7.695 | $7.41 | $7.49 | 16.79K |
Latest RMTI news
The latest Smart Investors Daily articles mentioning RMTI.
Stock researchCompany · Overview
Company
Market Activity
Research & News
RMTI research
Overview
Company profile and research snapshot.
Company profile
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $3.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | HC Wainwright & Co. | Buy | — |
| Jul 9, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 30, 2026 | HC Wainwright & Co. | Buy | — |
| Jan 26, 2026 | HC Wainwright & Co. | Buy | — |
| Nov 13, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Nov 12, 2026
Rockwell Medical (RMTI) Q3 2026 Earnings Call Transcript
Vantive deal reshapes the company's outlook as guidance is withdrawn.
Yahoo · Nov 12, 2026
Rockwell Medical: Q3 Earnings Snapshot
(RMTI) on Thursday reported a loss of $2.On a per-share basis, the Wixom, Michigan-based company said it had a loss of 59 cents.
Yahoo · Nov 12, 2026
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
Rockwell Medical (RMTI) delivered earnings and revenue surprises of -227.78% and +5.07%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
